ID

23028

Beschreibung

NCT00340080 / VIIV-CNA106030 https://clinicaltrials.gov/ct2/show/NCT00340080 A phase IV, randomised, multicentre, double-blind, study to evaluate the clinical utility of prospective genetic screening (HLA-B*5701) for susceptibility to abacavir hypersensitivity Assessment: Day 1 (Cohort Study) Medicine: abacavir, Condition: Infection, Human Immunodeficiency Virus, Phase: 4, Clinical Study ID: CNA106030, Sponsor: ViiV

Link

https://clinicaltrials.gov/ct2/show/NCT00340080

Stichworte

Versionen (1)
  1. 20.06.17 20.06.17 -
Hochgeladen am

20. Juni 2017

DOI

Für eine Beantragung loggen Sie sich ein.

Lizenz

Creative Commons BY 4.0
Modell Kommentare :

Hier können Sie das Modell kommentieren. Über die Sprechblasen an den Itemgruppen und Items können Sie diese spezifisch kommentieren.

Zurück zu Modell Kommentaren
Itemgroup Kommentare für :

Item Kommentare für :

Um Formulare herunterzuladen müssen Sie angemeldet sein. Bitte loggen Sie sich ein oder registrieren Sie sich kostenlos.

Genetic Screening For HLA-B*5701 n Patients with HIV Day 1 NCT00340080

Englisch

Genetic Screening For HLA-B*5701 Day 1 NCT00340080

1 Formulare  
Day 1
Beschreibung

Day 1

Alias
UMLS CUI-1
C1516637
UMLS CUI-2
C0009247
Subject Identifier
Beschreibung

Subject Identifier

Datentyp

text

Alias
UMLS CUI [1]
C2348585
Visit Date
Beschreibung

Visit Date

Datentyp

date

Alias
UMLS CUI [1]
C1320303
Is subject going to be followed prospectively in the cohort sub-study of HLA-B*5701 positive subjects?
Beschreibung

cohort sub-study

Datentyp

text

Alias
UMLS CUI [1,1]
C1516637
UMLS CUI [1,2]
C0009247
Has the subject previously received and permanently stopped antiretroviral therapy prior to Day 1?
Beschreibung

If Yes, record each medication on a separate line using Trade Names where possible.

Datentyp

text

Alias
UMLS CUI [1]
C1963724
Drug Name (Trade name preferred)
Beschreibung

If Yes, record each medication on a separate line using Trade Names where possible.

Datentyp

text

Alias
UMLS CUI [1,1]
C2360065
UMLS CUI [1,2]
C1963724
Start Date
Beschreibung

If Yes, record each medication on a separate line using Trade Names where possible.

Datentyp

date

Alias
UMLS CUI [1,1]
C0808070
UMLS CUI [1,2]
C1963724
Stop Date
Beschreibung

If Yes, record each medication on a separate line using Trade Names where possible.

Datentyp

date

Alias
UMLS CUI [1,1]
C0806020
UMLS CUI [1,2]
C1963724
Ongoing Medication?
Beschreibung

If Yes, record each medication on a separate line using Trade Names where possible.

Datentyp

text

Alias
UMLS CUI [1,1]
C2826666
UMLS CUI [1,2]
C1963724
Vital signs: Blood pressure systolic
Beschreibung

Blood pressure systolic

Datentyp

integer

Maßeinheiten
  • mmHg
Alias
UMLS CUI [1]
C0871470
mmHg
Vital signs: Blood pressure diastolic
Beschreibung

Blood pressure diastolic

Datentyp

integer

Maßeinheiten
  • mmHg
Alias
UMLS CUI [1]
C0428883
mmHg
Vital signs: Heart rate
Beschreibung

Heart rate

Datentyp

integer

Maßeinheiten
  • beats/minute
Alias
UMLS CUI [1]
C0018810
beats/minute
Vital signs: Temperature
Beschreibung

Temperature

Datentyp

float

Maßeinheiten
  • °C
Alias
UMLS CUI [1]
C0005903
°C
Zum Seitenanfang zurückkehren

Ähnliche Modelle

Genetic Screening For HLA-B*5701 Day 1 NCT00340080

1 Formulare
Name
Typ
Description | Question | Decode (Coded Value)
Datentyp
Alias
Item Group
Day 1
C1516637 (UMLS CUI-1)
C0009247 (UMLS CUI-2)
Subject Identifier
Item
Subject Identifier
text
C2348585 (UMLS CUI [1])
Visit Date
Item
Visit Date
date
C1320303 (UMLS CUI [1])
Item
Is subject going to be followed prospectively in the cohort sub-study of HLA-B*5701 positive subjects?
text
C1516637 (UMLS CUI [1,1])
C0009247 (UMLS CUI [1,2])
Eligibility Question
Code List
Is subject going to be followed prospectively in the cohort sub-study of HLA-B*5701 positive subjects?
CL Item
Yes (Y)
CL Item
No (N)
Item
Has the subject previously received and permanently stopped antiretroviral therapy prior to Day 1?
text
C1963724 (UMLS CUI [1])
Eligibility Question
Code List
Has the subject previously received and permanently stopped antiretroviral therapy prior to Day 1?
CL Item
Yes (Y)
CL Item
No (N)
Drug Name
Item
Drug Name (Trade name preferred)
text
C2360065 (UMLS CUI [1,1])
C1963724 (UMLS CUI [1,2])
Start Date
Item
Start Date
date
C0808070 (UMLS CUI [1,1])
C1963724 (UMLS CUI [1,2])
Stop Date
Item
Stop Date
date
C0806020 (UMLS CUI [1,1])
C1963724 (UMLS CUI [1,2])
Item
Ongoing Medication?
text
C2826666 (UMLS CUI [1,1])
C1963724 (UMLS CUI [1,2])
Eligibility Question
Code List
Ongoing Medication?
CL Item
Yes (Y)
CL Item
No (N)
Blood pressure systolic
Item
Vital signs: Blood pressure systolic
integer
C0871470 (UMLS CUI [1])
Blood pressure diastolic
Item
Vital signs: Blood pressure diastolic
integer
C0428883 (UMLS CUI [1])
Heart rate
Item
Vital signs: Heart rate
integer
C0018810 (UMLS CUI [1])
Temperature
Item
Vital signs: Temperature
float
C0005903 (UMLS CUI [1])
Zum Seitenanfang zurückkehren 

Kontakt

Benutzen Sie dieses Formular für Rückmeldungen, Fragen und Verbesserungsvorschläge.

Mit * gekennzeichnete Felder sind notwendig.

Hilfe

Benötigen Sie Hilfe bei der Suche? Um mehr Details zu erfahren und die Suche effektiver nutzen zu können schauen Sie sich doch das entsprechende Video auf unserer Tutorial Seite an.

Zum Video